This site is intended for healthcare professionals

Round Up Email March 2021

Highlights in this month's Round Up include an algorithm using SGLT2 inhibitors in heart failure with reduced ejection fraction; an update of the chronic suppurative otitis media section on GPnotebook; and guidance regarding the antibiotic management of infected eczema.

  • Question 1

    The section on chronic suppurative otitis media has been updated on GPnotebook. How is CSOM diagnosed? What are the red flags? Are systematic antibiotics indicated?: Chronic suppurative otitis media (CSOM)

    1) Which statement regarding chronic suppurative otitis media is false

  • Question 2

    Itchiness in the patient with end-stage kidney disease. Is it common? How should this condition be managed?: Uraemic pruritus

    2) Which statement regarding uraemic pruritus is false

  • Question 3

    Frostbite and frostnip – an update of this section in GPnotebook.: Frostbite

    3) Which statement regarding frostbite and frostnip is false

  • Question 4

    Infected eczema – which antibiotics are indicated? An update reflecting latest NICE guidance.: Infected eczema

    4) Which statement regarding infected eczema is false

  • Question 5

    Management of HFrEF in newly diagnosed patients. A summary of an algorithm using evidence based therapies in HFrEF.: Proposed algorithm for chronic reduced ejection fraction heart failure (HFrEF) by McMurray and Packer 2020

    5) Which statement regarding the proposed algorithm for chronic reduced ejection fraction heart failure (HFrEF) is false

  • Question 6

    Mirocytosis without anaemia – is this a potential marker of undiagnosed cancer?: Microcytosis without anaemia and cancer risk

    6) Which statement regarding microcytosis without anaemia and cancer risk is false

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.